Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.

ABSTRACT:

Background and objectives

Vaccination with Human Papillomavirus (HPV) vaccine is recommended for 11-12 years-old, but uptake is suboptimal. Current messaging focuses on HPV infection transmission and prevention. Parents and providers are often uncomfortable discussing sexual practices of adolescents, contributing to the delay/refusal of vaccine. We created a cervical cancer-salient message encouraging HPV vaccination, emphasizing disease salience and disease threat, while promoting self-efficacy. We hypothesized this message would have greater effects on vaccine confidence and intent to vaccinate compared to Centers for Disease Control and Prevention (CDC) and non-vaccine control messages.

Methods

A 3-arm randomized trial was conducted. Parents of girls aged 9-17 were eligib

SUBMITTER: Porter RM 

PROVIDER: S-EPMC6550298 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature